Enochian BioSciences announced that it has achieved full compliance with NASDAQ filing requirements. The Annual Report on Form 10-K was filed on February 27, 2023, followed by the Quarterly Reports on Forms 10-Q for the quarters ending September 30, 2022 and December 31, 2022 on March 7th and March 9th, 2023, respectively.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ENOB:
